GABAA receptor screening enables detailed evaluation of subtype-selective modulation using automated electrophysiology. Sygnature Discovery supports CNS drug discovery with robust assay platforms for characterizing GABAA receptor activity and pharmacology....
Subtype selective GABAA modulation
read more